PolyNovo Limited (PNV.AX)
AUD 1.06
(8.21%)
AUD 1.06
(8.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 5.17 Million AUD | 290.81% |
| 2023 | -2.7 Million AUD | -353.27% |
| 2022 | 961.93 Thousand AUD | 175.86% |
| 2021 | -3.4 Million AUD | 38.51% |
| 2020 | -3.2 Million AUD | -16.6% |
| 2019 | -3.19 Million AUD | 50.36% |
| 2018 | -6.27 Million AUD | -16.51% |
| 2017 | -5.59 Million AUD | -48.13% |
| 2016 | -3.87 Million AUD | -18.24% |
| 2015 | -3.76 Million AUD | 4.73% |
| 2014 | -3.68 Million AUD | 8.42% |
| 2013 | -2.92 Million AUD | 21.51% |
| 2012 | -3.28 Million AUD | -12.66% |
| 2011 | -3.63 Million AUD | -45.71% |
| 2010 | -2.58 Million AUD | 1.61% |
| 2009 | -2.13 Million AUD | 47.17% |
| 2008 | -4.17 Million AUD | 64.98% |
| 2007 | -13.66 Million AUD | -11.12% |
| 2006 | -12.29 Million AUD | -8.59% |
| 2005 | -10.58 Million AUD | 7.15% |
| 2004 | -12.19 Million AUD | -33.22% |
| 2003 | -9.15 Million AUD | -265.91% |
| 2002 | -4.18 Million AUD | 50.47% |
| 2001 | -5.05 Million AUD | -42.25% |
| 2000 | -3.55 Million AUD | -118.08% |
| 1999 | -1.62 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 2.17 Million AUD | 0.0% |
| 2024 Q2 | 877 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 199.96% |
| 2023 Q4 | -867.26 Thousand AUD | 0.0% |
| 2023 FY | - AUD | -353.27% |
| 2023 Q2 | -2.6 Million AUD | 0.0% |
| 2022 Q4 | -850.3 Thousand AUD | 0.0% |
| 2022 Q2 | 2.52 Million AUD | 0.0% |
| 2022 FY | - AUD | 175.86% |
| 2021 FY | - AUD | 38.51% |
| 2021 Q2 | -1.63 Million AUD | 0.0% |
| 2021 Q4 | -730.75 Thousand AUD | 0.0% |
| 2020 FY | - AUD | -16.6% |
| 2020 Q2 | -2 Million AUD | 0.0% |
| 2020 Q4 | -1.24 Million AUD | 0.0% |
| 2019 Q2 | -1.98 Million AUD | 0.0% |
| 2019 Q4 | -1.6 Million AUD | 0.0% |
| 2019 FY | - AUD | 50.36% |
| 2018 FY | - AUD | -16.51% |
| 2018 Q2 | -3.05 Million AUD | 0.0% |
| 2018 Q4 | -2.65 Million AUD | 0.0% |
| 2017 Q2 | -1.94 Million AUD | 0.0% |
| 2017 FY | - AUD | -48.13% |
| 2017 Q4 | -2.95 Million AUD | 0.0% |
| 2016 Q4 | -1.03 Million AUD | 0.0% |
| 2016 Q2 | -2.27 Million AUD | 0.0% |
| 2016 FY | - AUD | -18.24% |
| 2015 FY | - AUD | 4.73% |
| 2015 Q4 | -1.44 Million AUD | 0.0% |
| 2015 Q2 | -1.35 Million AUD | 0.0% |
| 2014 FY | - AUD | 8.42% |
| 2014 Q4 | -1.8 Million AUD | 0.0% |
| 2014 Q2 | -1.13 Million AUD | 0.0% |
| 2013 Q3 | -336.92 Thousand AUD | 48.28% |
| 2013 Q4 | -867.25 Thousand AUD | -157.4% |
| 2013 FY | - AUD | 21.51% |
| 2013 Q2 | -651.46 Thousand AUD | -0.24% |
| 2013 Q1 | -649.88 Thousand AUD | 0.0% |
| 2012 Q2 | -649.88 Thousand AUD | 21.49% |
| 2012 Q1 | -827.82 Thousand AUD | 0.0% |
| 2012 Q4 | -649.88 Thousand AUD | 0.0% |
| 2012 Q3 | -649.88 Thousand AUD | 0.0% |
| 2012 FY | - AUD | -12.66% |
| 2011 Q4 | -827.82 Thousand AUD | 0.0% |
| 2011 Q1 | -512.25 Thousand AUD | 0.0% |
| 2011 FY | - AUD | -45.71% |
| 2011 Q3 | -827.82 Thousand AUD | 0.0% |
| 2011 Q2 | -827.82 Thousand AUD | -61.6% |
| 2010 Q2 | -512.25 Thousand AUD | 3.91% |
| 2010 FY | - AUD | 1.61% |
| 2010 Q3 | -512.25 Thousand AUD | 0.0% |
| 2010 Q4 | -512.25 Thousand AUD | 0.0% |
| 2010 Q1 | -533.1 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 47.17% |
| 2009 Q3 | -533.1 Thousand AUD | 0.0% |
| 2009 Q1 | -1.04 Million AUD | 0.0% |
| 2009 Q4 | -533.1 Thousand AUD | 0.0% |
| 2009 Q2 | -533.1 Thousand AUD | 48.92% |
| 2008 Q1 | -3.27 Million AUD | 0.0% |
| 2008 FY | - AUD | 64.98% |
| 2008 Q4 | -1.04 Million AUD | 0.0% |
| 2008 Q3 | -1.04 Million AUD | 0.0% |
| 2008 Q2 | -1.04 Million AUD | 68.15% |
| 2007 Q2 | -3.27 Million AUD | -19.09% |
| 2007 Q4 | -3.27 Million AUD | 0.0% |
| 2007 Q3 | -3.27 Million AUD | 0.0% |
| 2007 FY | - AUD | -11.12% |
| 2007 Q1 | -2.75 Million AUD | 0.0% |
| 2006 Q3 | -2.75 Million AUD | 0.0% |
| 2006 Q4 | -2.75 Million AUD | 0.0% |
| 2006 FY | - AUD | -8.59% |
| 2006 Q2 | -2.75 Million AUD | 48.31% |
| 2006 Q1 | -5.32 Million AUD | 0.0% |
| 2005 Q1 | -3.04 Million AUD | 0.0% |
| 2005 Q4 | -5.32 Million AUD | 0.0% |
| 2005 Q3 | -5.32 Million AUD | 0.0% |
| 2005 Q2 | -5.32 Million AUD | -74.61% |
| 2005 FY | - AUD | 7.15% |
| 2004 Q1 | -4.28 Million AUD | 0.0% |
| 2004 FY | - AUD | -33.22% |
| 2004 Q2 | -3.04 Million AUD | 28.82% |
| 2004 Q4 | -3.04 Million AUD | 0.0% |
| 2004 Q3 | -3.04 Million AUD | 0.0% |
| 2003 Q3 | -4.28 Million AUD | 0.0% |
| 2003 Q4 | -4.28 Million AUD | 0.0% |
| 2003 Q2 | -4.28 Million AUD | -50.05% |
| 2003 Q1 | -2.85 Million AUD | 0.0% |
| 2003 FY | - AUD | -265.91% |
| 2002 Q3 | -2.85 Million AUD | 0.0% |
| 2002 Q4 | -2.85 Million AUD | 0.0% |
| 2002 Q2 | -2.85 Million AUD | -12.82% |
| 2002 FY | - AUD | 50.47% |
| 2002 Q1 | -2.53 Million AUD | 0.0% |
| 2001 Q3 | -2.53 Million AUD | 0.0% |
| 2001 FY | - AUD | -42.25% |
| 2001 Q4 | -2.53 Million AUD | 0.0% |
| 2001 Q2 | -2.53 Million AUD | -42.27% |
| 2001 Q1 | -1.77 Million AUD | 0.0% |
| 2000 FY | - AUD | -118.08% |
| 2000 Q1 | -815.96 Thousand AUD | 0.0% |
| 2000 Q2 | -1.77 Million AUD | -117.97% |
| 2000 Q3 | -1.77 Million AUD | 0.0% |
| 2000 Q4 | -1.77 Million AUD | 0.0% |
| 1999 Q2 | -815.96 Thousand AUD | 0.0% |
| 1999 Q3 | -815.96 Thousand AUD | 0.0% |
| 1999 Q4 | -815.96 Thousand AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 114.335% |
| Adherium Limited | -11.56 Million AUD | 144.706% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 170.244% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 195.326% |
| Anteris Technologies Ltd | -66.9 Million AUD | 107.727% |
| Control Bionics Limited | -5.15 Million AUD | 200.229% |
| CardieX Limited | -6.71 Million AUD | 177.028% |
| Compumedics Limited | 2.78 Million AUD | -85.371% |
| Cochlear Limited | 579.5 Million AUD | 99.108% |
| CleanSpace Holdings Limited | -3.49 Million AUD | 248.061% |
| Cyclopharm Limited | -3.03 Million AUD | 270.352% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | 347.226% |
| Nova Eye Medical Limited | -5.97 Million AUD | 186.469% |
| HeraMED Limited | -3.97 Million AUD | 230.159% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 123.639% |
| ImpediMed Limited | -22.05 Million AUD | 123.446% |
| InhaleRx Limited | -1.41 Million AUD | 465.696% |
| LBT Innovations Limited | -4.04 Million AUD | 227.686% |
| Micro-X Limited | -14.35 Million AUD | 136.025% |
| Neurotech International Limited | -8.24 Million AUD | 162.712% |
| OncoSil Medical Limited | -11.97 Million AUD | 143.169% |
| Respiri Limited | -7.04 Million AUD | 173.334% |
| SomnoMed Limited | -2.32 Million AUD | 322.021% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 156.873% |
| Uscom Limited | -1.5 Million AUD | 442.541% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 205.137% |